Market Overview

Esperion Therapeutics (NASDAQ: ESPR)

43.02 -0.07 (-0.17%)

Analyst Ratings

DateResearch FirmActionCurrentPT
12/13/18Goldman SachsInitiates Coverage OnSell45.0
10/16/18BTIG ResearchInitiates Coverage OnBuy82.0
8/17/18CitigroupUpgradesBuy75.0
7/11/18Northland SecuritiesDowngradesMarket Perform0.0
5/04/18Credit SuisseMaintainsOutperform73.0
5/03/18JP MorganDowngradesUnderweight
5/03/18Deutsche BankMaintainsBuy75.0
5/02/18Bank of AmericaDowngradesUnderperform
3/27/18Chardan CapitalMaintainsNeutral100.0
2/21/18UBSMaintainsNeutral90.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter